Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Amots who wrote (19203)	3/3/1999 10:58:00 AM
From: RT	Read Replies (1) \| Respond to of 23519

<<They got new Patent for Treatment of female sexual dysfunction.>> Good news and the stock price goes down. Bad news and the stock price goes down. No news and the stock price goes down. No volume and the price goes down. Do I see a pattern developing here? RT

To: Amots who wrote (19203)	3/3/1999 11:50:00 AM
From: Little Gorilla	Read Replies (1) \| Respond to of 23519

Alert -- stupid question here... I just read the patent info. What the heck is the invention? It's like their claiming the rights to everything that may possibly work. They even have MCHM's transdermal delivery system in there: >>The formulations may also include one or more components to enhance permeation of the vasodilating agent, i.e., "permeation enhancers." Suitable permeation enhancers include those generally useful in conjunction with topical, transdermal or transmucosal drug delivery. Examples of suitable permeation enhancers include... SEPA.RTM. (available from Macrochem Co., Lexington, Mass.)...<<